Patients undergoing intensive chemotherapy for acute myeloid leukemia are routinely treated with multiple antibiotics to prevent infection, a practice that new research from Texas A&M University shows can significantly reshape the gut microbiome and influence the risk of antibiotic-resistant infections.
This article was originally published on MedicalXpress.com

